论文部分内容阅读
心律平是近年来用于临床的一种新的IC类抗心律失常药物。静脉注射能有效地终止阵发性室上性心动过速(PSVT)的发作,现简要报告临床应用于25例PSVT的疗效,并分析如下。一、临床资料 25例病人中男性18例,女性7例。年龄20～58岁,预激综合征5例,原发性PSVT11侧,高血压心脏病2例,冠心病7例。病史最短20分钟,最长者8年,既往发作曾使用西地兰治疗6例,异搏定10例,利多卡因2例,首次发作7例。确诊后将心律平70mg加葡萄糖20毫升,缓慢推注(一般3-5min推完),同时心电监护,恢复窦性心律立即停止注射,改为口服心律平150mg,
Cardiac rhythm is a new class of IC antiarrhythmic drugs used clinically in recent years. Intravenous injection can effectively stop the onset of paroxysmal supraventricular tachycardia (PSVT), is now a brief report of the clinical application of 25 cases of PSVT curative effect, and analyzed as follows. First, the clinical data of 25 patients, 18 males and 7 females. Age 20 to 58 years old, pre-excitation syndrome in 5 cases, primary PSVT11 side, hypertension heart disease in 2 cases, 7 cases of coronary heart disease. The shortest history of 20 minutes, the longest 8 years, previous episodes of cedilanid 6 cases, verapamil 10 cases, lidocaine in 2 cases, the first episode in 7 cases. After the diagnosis of heart rhythm 70mg plus glucose 20 ml, slow bolus (usually 3-5min push finished), while ECG monitoring, sinus rhythm immediately stop injection, to oral rhythm of heart 150mg,